Psoriasis Treatment Ixekizumab Safe for Cardiovascular Health
Biologic therapies for psoriasis may have an impact on cardiovascular parameters, potentially resulting in the occurrence of major adverse cardiovascular events.
All articles by Sunali Wadehra
Combination Therapy for Acne May Be Good Alternative to Isotretinoin
On subject questionnaire, 83.2% participants reported being “satisfied” or “very satisfied” with study treatment, and 90.2% subjects reported moderate symptomatic improvement.
Cellulite Effectively Reduced With Concurrent Radiofrequency, Pressure Energy Treatment
These results demonstrate that the simultaneous application of radiofrequency and targeted pressure energy is a safe and effective treatment option for cellulite.
Melanocytic Skin Lesions Best Interpreted By Experienced, Specialized Pathologists
Pathologist characteristics, including level of experience and training, were analyzed in association with these assessments using multivariable logistic regression modeling.
Increased Vitamin D Via Narrow Band UVB Therapy May Improve Vitiligo Symptoms
Narrow-band ultraviolet B is a common therapy for vitiligo, and in nonsegmental vitiligo covering at least 20% of the body surface, it is the first-line treatment.
Differentiating Responders to Systemic Therapies From Nonresponders With Psoriasis
Treatment decisions are difficult to make in psoriasis patients, given the paucity of objective tools for evaluation of response to treatment.
Sarecycline Safe, Effective for Treatment of Acne Vulgaris
Although this study is limited by its small sample size, the evidence suggests that oral sarecycline 1.5 mg/kg administered once daily may be a viable treatment option for moderate to severe acne.
Shortness of Breath in Psoriasis May Be Linked to Reduced FEV1
Psoriasis is a chronic inflammatory systemic disease associated with several comorbid conditions, including chronic obstructive pulmonary disease and asthma.
Psoriasis Disease Perceptions Differ Between Patients, Dermatologists
Further communication between the patient and provider is needed to better understand the impact of disease severity and treatment.
Guselkumab More Effective Than Adalimumab for Reduction of Psoriasis Symptoms
Investigators analyzed data from the first year of VOYAGE 1, an ongoing, phase 3, double-blind, controlled trial of patients with moderate to severe psoriasis.
- Loading...
Loading...
Next post in Psoriasis
Loading... 
Loading...